I cover the latest PC hardware from the likes of AMD, Intel and Nvidia, including launches of the latest graphics card processors with my own benchmarks as well as covering the latest news and trends
Today Intel has launched its 14th Gen Raptor Lake refresh desktop processors, which promise better gaming and content creation performance and here we'll be taking a look at the Core i5-14600K and comparing it against 12th and 13th Gen Intel CPUs as well as those from AMD's Ryzen 7000 series, including its 3D V-cache models.
As with all 14th Gen CPUs, their main issue if you own an even older Intel CPU or AMD Socket AM4 CPU, is that there is no upgrade path. Motherboards and memory are cheaper than AMD's Socket AM5 route, but that has another few generations of processors planned for it.Intel has a decent allrounder in the Core i5-14600K which is much faster than the Ryzen 7 7700X and 7800X3D in most content creation tasks and a match or better than the former in games.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Intel Core i9-14900K and Core i5-14600K review: a solid stopgapIntel's new Core i9-14900K and Core i5-14600K close the gap with the competition from AMD, but they provide little reason to jump ship.
Read more »
Pathfinder 2E Announces New Book, Reveals New Addition to Core PantheonPathfinder is shaking up its pantheon of core deities with Lost Omens: Divine Mysteries
Read more »
Intel hits 6GHz (again) with its 14th-gen desktop CPUsIntel's 14th-gen desktop CPUs will hit 6GHz, just like its fastest 13th-gen chip.
Read more »
Core upgrades confidence in BP33 resourceLithium miner Core Lithium has reported an increase in the mineral resource estimate at its BP33 deposit, in the Northern Territory. As part of the works programme to update the feasibility study for BP33, Core has increased the mineral resource from 10.1-million tonnes, at 1.48% lithium oxide, to 10.5-million tonnes at 1.53% lithium oxide.
Read more »
UBS upgrades this 'core' health care stock, sees nearly 20% upsideThe firm upgraded shares of the health care giant to buy from neutral and raised its target price to $640 from $520.
Read more »